Diane Thibeault
Boehringer Ingelheim (Canada)(CA)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Monoclonal and Polyclonal Antibodies Research, Hepatitis B Virus Studies, HIV Research and Treatment
Most-Cited Works
- → An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus(2003)911 cited
- → Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors(1996)296 cited
- → Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors(1997)254 cited
- → Peptide-based inhibitors of the hepatitis C virus serine protease(1998)162 cited
- → Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease(2010)109 cited
- → Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors(2000)108 cited
- → An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA(2003)91 cited
- → Sensitivity of NS3 Serine Proteases from Hepatitis C Virus Genotypes 2 and 3 to the Inhibitor BILN 2061(2004)84 cited
- → Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease(1998)84 cited
- → Solution Structure of Substrate-based Ligands When Bound to Hepatitis C Virus NS3 Protease Domain(1999)75 cited